“…Cefovecin is a third‐generation cephalosporin currently approved for the treatment of skin infections in domestic dogs and cats in the United States (Stegemann, Passmore, et al, 2006; Stegemann, Sherington, and Blanchflower, et al, 2006; Stegemann, Sherington, Coati, et al, 2006; Stegemann et al, 2007), and additionally for feline urinary tract infections in other countries (Burke et al, 2017; Dokuzeylül et al, 2015; Passmore et al, 2008). Interpretive categories and breakpoints for cefovecin have been established by the Clinical Laboratory Standards Institute (CLSI) for testing pathogens from dogs and cats (CLSI, 2020).…”